JPH03106891A - Phosphatidylcholine derivative - Google Patents

Phosphatidylcholine derivative

Info

Publication number
JPH03106891A
JPH03106891A JP24096289A JP24096289A JPH03106891A JP H03106891 A JPH03106891 A JP H03106891A JP 24096289 A JP24096289 A JP 24096289A JP 24096289 A JP24096289 A JP 24096289A JP H03106891 A JPH03106891 A JP H03106891A
Authority
JP
Japan
Prior art keywords
formula
compound
expressed
compound expressed
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP24096289A
Other languages
Japanese (ja)
Inventor
Mitsunori Ono
光則 小野
Yoshihisa Tsukada
芳久 塚田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP24096289A priority Critical patent/JPH03106891A/en
Publication of JPH03106891A publication Critical patent/JPH03106891A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

NEW MATERIAL:A compound expressed by formula I (n is 8-22; R and R1 are alkoxy or H). USE:Useful in assembling a light-responsive liposome system for medicine or agricultural chemical. The compound expressed by formula I is a compound containing a m-methoxybenzyl group which is a highly efficient light accepting group in the end of hydrophobic part and can be synthesized in good efficiency. PREPARATION:An acid chloride expressed by formula II is reacted with m- methoxybenzyl alcohol (derivative) expressed by formula III in a polar aprotic solvent and then the reaction product is subjected to after-treatment with water to afford a compound expressed by formula IV. Then the compound expressed by formula IV is condensed with phosphatidylglycerol expressed by formula V, e.g. by a method dissolving the compound expressed by formula IV, 4- dimethylaminopyridine and dicyclohexylcarbodiimide which is a condensing agent in chloroform, adding CdCl2 salt of compound expressed by formula V thereto and stirring the mixture.

Description

【発明の詳細な説明】 (発明の分野) 本発明は、光応答性リボンーム系を構築するのKW用な
、疎水部末端に光受容基を有するホスファチジルコリン
誘導体に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of the Invention) The present invention relates to a phosphatidylcholine derivative having a photoaccepting group at the end of the hydrophobic portion, which is useful for constructing a photoresponsive ribbon-like system.

(従来技術) ホス7アチジルコリンに光受容基を導入した例としては
、Chemistry  Letters(ケミストリ
ー・レターズ)aSS頁、lタtタ年に光受容基として
O−ニトロベンジル基を用いた例が記載されている。し
かしこの化合物は光反応性が乏しく、1た光照射により
開裂して放出される0−二トロベンジル基は、0−ニト
ロンベンヅアルデヒドというきわめて危険な発ガン性の
疑がいのある物質に変化するという致命的な欠点が指摘
されており、高効率かつ安全な光受容基の開発が望筐れ
ていた。
(Prior Art) As an example of introducing a photoaccepting group into phos-7-acylcholine, an example of using an O-nitrobenzyl group as a photoaccepting group is described in Chemistry Letters, page aSS, 2010. ing. However, this compound has poor photoreactivity, and the 0-nitrobenzyl group that is cleaved and released by light irradiation converts into 0-nitrobenzaldehyde, an extremely dangerous substance suspected of being carcinogenic. This fatal drawback has been pointed out, and the development of highly efficient and safe photoreceptive groups has been desired.

(発明の目的) 従って、本発明の目的は、高効率な光受容基であるm−
メトキシベンジル基を疎水部末端に有するホス7アチジ
ルコリン誘導体を提供することである。
(Object of the Invention) Therefore, the object of the present invention is to provide m-
An object of the present invention is to provide a phos-7 atidylcholine derivative having a methoxybenzyl group at the end of the hydrophobic part.

(発明の構収) 本発明のホス7アチジルコ で表わされる化合物である。(Collection of invention) Phos-7-acydylco of the present invention It is a compound represented by

式1 リン誘導体は下式1 O 式1中、nはr−22の整数を表わす。Formula 1 The phosphorus derivative is the following formula 1 O In Formula 1, n represents an integer of r-22.

式1中、RとR.はアルコキシ基か水素原子を表わす,
上記アルコキシ基は特に低級アルコキシ基(メトキシ基
など)である. 以下に本発明の好筐しい具体例k物性値と共に列挙する
In formula 1, R and R. represents an alkoxy group or a hydrogen atom,
The alkoxy group mentioned above is particularly a lower alkoxy group (such as a methoxy group). Preferred specific examples of the present invention are listed below along with physical property values.

化合物 A6 R H H H O C H s H OCH3 H OCR. H OCH3 H 物 一to  0c − 7 °C //’C I? ″′C az’c ダ1C t4A ’c zt  0c 44L ’C 67 °C ぶ7 °C 〔α〕25 D 〔α)25 D 〔α〕25 D 〔α〕25 D 〔α〕25 D 〔α〕25 D 〔α〕25 D 〔α〕25 D 〔α〕25 D 〔α)25 D 〔α)25 D 性 値 +0.02 +0.02 +o . or +0.02 +0.02 +0./ 十o.otr +0./ +0./ +0.01 +0.2 (CHCt3 (CHcts (CHα3 (CHα3 ( C HCI 3 (CHα3 (cHct3 (CHα3 (CHα3 (CHα3 (CHα3 (7.j) 0.j) O.!) 0.2冫 0.7j) (7.j) Q.!》 O.!} O.!》 o.r冫 O.!) 次に本発明の化合物を合成する為の方法の概略と実際の
合戚方法の例を示すが、本発明の化合物の合戚方法はこ
の経路に限定されるものではない。
Compound A6 R H H H O C H s H OCH3 H OCR. H OCH3 H thing to 0c - 7 °C //'C I? '''C az'c da1C t4A 'c zt 0c 44L 'C 67 °C bu7 °C [α]25 D [α)25 D [α]25 D [α]25 D [α]25 D [α ]25 D [α]25 D [α]25 D [α]25 D [α)25 D [α)25 D Sex value +0.02 +0.02 +o. or +0.02 +0.02 +0./ 10o .otr +0./ +0./ +0.01 +0.2 (CHCt3 (CHcts (CHα3 (CHα3 (CHα3 (7.j) 0.j) O.! ) 0.2ㆫ0.7j) (7.j) Q.!》 O.!} O.!》 o.r冫O.!) Next, outline and actual method for synthesizing the compound of the present invention. An example of the method for combining the compounds of the present invention is shown below, but the method for combining the compounds of the present invention is not limited to this route.

合成経路概略 Aで表わされる酸クロライドをBで表されるm一メトキ
シベンジルアルコール又はその誘導体とTHF等の極性
非プロトン溶媒中で反応させlケのエステル部を生戚さ
せ、その後、水で後処理することにより、化合物Cに導
く。
Synthetic Route Outline The acid chloride represented by A is reacted with m-methoxybenzyl alcohol or its derivative represented by B in a polar aprotic solvent such as THF to form l ester moieties, and then the mixture is reacted with water. The treatment leads to compound C.

次に化合物Cと市販のホスファチジルグリセロールDi
ジシクロヘキシルカルボジイミド等の縮合剤を用いて縮
合させることにより目的とする化合物を効率良く合収で
きる。
Next, compound C and commercially available phosphatidylglycerol Di
By condensing using a condensing agent such as dicyclohexylcarbodiimide, the target compound can be efficiently synthesized.

本発明の化合物(式1)は、医薬用、農薬用、化粧品用
等の光応答性リポソームを形戚させる場合の光受容基を
含むリン脂質として有用である。
The compound of the present invention (formula 1) is useful as a phospholipid containing a photoreceptor group when forming photoresponsive liposomes for pharmaceuticals, agricultural chemicals, cosmetics, and the like.

その応答のメカニズムは下式に示すようなものである。The response mechanism is as shown in the equation below.

妙 式1 目的化合物 すなわち1は光照射を受け、疎水部末端が開裂し、結果
的Vc2と3が得られる。2はリポソーム(2分子膜)
′t−維持するに足る親水、疎水性のバランスはくずれ
ており膜構造が乱れ、内包物が放出されることになるの
である。
Mysterious Formula 1 The target compound, ie, 1, is irradiated with light, the hydrophobic end is cleaved, and Vc2 and 3 are obtained as a result. 2 is liposome (bilayer membrane)
The balance between hydrophilicity and hydrophobicity sufficient to maintain 't- is lost, the membrane structure is disturbed, and the inclusions are released.

次に示す溶液系でのモデル実験から明らかな通り、m−
メトキシベンジル系の光受容基D7g63、4、7)0
−ニトロベンジル系(/i68 )と較べて/0倍以上
も反応速度が大きく、壕た開裂後は安全ナべ冫ジルアル
コールになることが確認された。
As is clear from the model experiment in the solution system shown below, m-
Methoxybenzyl photoreceptor group D7g63,4,7)0
- It was confirmed that the reaction rate was more than 0 times higher than that of the nitrobenzyl type (/i68), and that it became a safe nabezyl alcohol after trench cleavage.

参考例(溶液系での置換基効果の災験)使用化合物 O 光源 !W 低圧水銀ランプ(zj4cnm)石英セル
;基質JmM  アセトニトリル/リン酸緩衝液室温 
           pH=7゜Q光反応の相対反応
効率“ 16  R2  R3  R4  R5  R6   
分解(1)   生w!i.(n)mln  X/(7
    mtn  X#71.OCH30CH3  H
  H   H2.  H  OCHa 00{a H
   H3.  H  α田3  H  OCH3  
H4.  H  OCHa  H   H  OCHa
5.  H  OC’Ha  CI  H   H6.
  H  OCH3  H   H   (?/!7.
  H  (X,’H3  H   H   Hs.N
O2  H   H  H   H7./ /4t.! /03 37.6 t.l /7.4I 亭6.j 44./ 6.6 lλ.6 62.2 3j.3 6.Q /0./ l7.7 3.0 / R4 R4 ただし O.D.は2j←nmの吸光度実施例l 化合物41 ( n=r%R=R1 =H)の合戚(1
)  化合物A(n=r)の合成 デカンニrR/009fチオニルクロライドlOOn!
,トルエンioowに加え、/0時間加熱還流した。I
Rでカルボン酸の吸収が消失し、酸クaライドの吸収が
生戚したことを確認したのちに反応液を減圧濃縮して、
化合物A(n=r)//ry<定量的)に得た。
Reference example (disaster of substituent effect in solution system) Compound used Light source! W low pressure mercury lamp (zz4cnm) quartz cell; substrate JmM acetonitrile/phosphate buffer room temperature
pH=7゜Relative reaction efficiency of Q photoreaction " 16 R2 R3 R4 R5 R6
Decomposition (1) Raw lol! i. (n) mln X/(7
mtnX#71. OCH30CH3H
H H2. H OCHa 00{a H
H3. H α field 3 H OCH3
H4. H OCHa H H OCHa
5. H OC'Ha CI H H6.
H OCH3 H H (?/!7.
H (X,'H3 H H Hs.N
O2 H H H H7. / /4t. ! /03 37.6 t. l /7.4I Tei6. j44. / 6.6 lλ. 6 62.2 3j. 3 6. Q/0. / l7.7 3.0 / R4 R4 However, O. D. is the absorbance of 2j←nm Example l Compound 41 (n=r%R=R1=H)
) Synthesis of compound A (n=r) Decanni rR/009f thionyl chloride lOOn!
, toluene ioow and heated under reflux for /0 hour. I
After confirming that the absorption of carboxylic acid disappeared and the absorption of acid chloride was completed in R, the reaction solution was concentrated under reduced pressure.
Compound A (n=r)//ry<quantitative) was obtained.

I R (−Coα)/I00cm−”(2)  化合
物C(n=r)の合成( R=R 1 =H )m−メ
トキ7ベンジルアルコール/ j . If/およぴト
リエチルアミン/0./9をTHF s o odに溶
解した溶液金、化合物A(n=r).2J.2gをTH
p200ydに溶解した溶液に滴下し室温にて!時間攪
拌した。飽和炭酸水素ナトリウム水200ml1′反応
液に加えて20分間攪拌し、酢酸エチル200−で抽出
した。さらに水層を酢酸エチル!OQ一で抽出し、有機
層を集めて硫酸ナトリウムで乾燥した。硫酸ナトリウム
fc!別した後に、a液を減圧tlmLて茶かつ色の油
状物質を得た。
I R (-Coα)/I00cm-" (2) Synthesis of compound C (n=r) (R=R1=H) m-methoxy7benzyl alcohol/j.If/and triethylamine/0./9 A solution of gold, compound A (n=r).2J.2g dissolved in THF so od was dissolved in THF.
Add dropwise to a solution dissolved in p200yd at room temperature! Stir for hours. 200 ml of saturated sodium bicarbonate water was added to the reaction mixture, stirred for 20 minutes, and extracted with 200 ml of ethyl acetate. Furthermore, remove the aqueous layer with ethyl acetate! After extraction with OQ1, the organic layer was collected and dried over sodium sulfate. Sodium sulfate fc! After separation, liquid a was vacuum-tlmL to obtain a brown oily substance.

?の反応混合物をシリカゲルカラムクロマトグラフイー
(溶離液 ヘキサン/酢酸エチル填3//(v/v)に
て精製し、油状物質化合物C(n=t)tsg<収率4
cts>’t得た。
? The reaction mixture was purified by silica gel column chromatography (eluent: hexane/ethyl acetate 3//(v/v)) to obtain an oily compound C (n=t)tsg<yield 4
cts>'t got.

以下に物性値を示す。The physical property values are shown below.

IR(neatL ’ (エステル)/74AOcm−
”ν(カルボン酸)/700cm−” (3)縮合反応 化合物Dのメタノール溶液(日本精化■品)6θ−(.
27w/v優)を減圧濃縮し、エタノール7001df
加(た。tjK化力}’ミ17 A (Cdct2 −
J .jH20)J■Ji’eFj*ethamol 
 .2FORlに溶解し、化合物Dのエタノール溶液に
滴下した。l0Cにてl2時間放置したのち、白色沈殿
物ヲ口過し、エタノールで2回、エーテルで2回洗浄し
た。乾燥後、白色粉末(化合物D)2(Cdα2》3 
を.2.2 .Oji得た。
IR (neatL' (ester)/74AOcm-
"ν(carboxylic acid)/700cm-" (3) Methanol solution of condensation reaction compound D (Nippon Fine Chemicals product) 6θ-(.
27 w/v excellent) was concentrated under reduced pressure to obtain 7001 df of ethanol.
Add (ta. tjK power}'Mi17 A (Cdct2 -
J. jH20)J■Ji'eFj*ethamol
.. It was dissolved in 2FORl and added dropwise to the ethanol solution of Compound D. After standing at 10C for 12 hours, the white precipitate was filtered off and washed twice with ethanol and twice with ether. After drying, white powder (compound D) 2 (Cdα2》3
of. 2.2. I got Oji.

化合物C(nエr)tx.2g,φ−ジメチルアミノピ
リジンx.pg,ジンクロへキクルカルボジイミドt.
zyをクロロホルム/00mlに溶解し、化合物DのC
 d Cl 2塩ダ.6gを加え、室温で3日間攪拌し
た。この反応混合物をアン,?−ライト/R−l,2Q
B(溶離液 クロロホルム/メタノール/水=U/!/
/)にてイオン交換し、さらκシリカゲルクロマトグラ
フイー(溶離液クCIICIホルム/メタノール/水=
6!/コz7a )で精製した。溶離液を減圧濃縮し、
/00mlのクロロホルムを加え、水洗した。硫酸ナト
リウムで乾燥後、減圧濃縮して、油状物質化合物A 1
1 .t .09(収率70%)得た。
Compound C(ner)tx. 2g, φ-dimethylaminopyridine x. pg, zinclohekiclcarbodiimide t.
Dissolve zy in chloroform/00ml and add C of compound D.
d Cl 2 salt da. 6 g was added and stirred at room temperature for 3 days. This reaction mixture is an? -Light/R-l, 2Q
B (eluent chloroform/methanol/water = U/!/
/) and further κ silica gel chromatography (eluent: CIICI form/methanol/water =
6! /coz7a). Concentrate the eluent under reduced pressure,
/00ml of chloroform was added and washed with water. After drying with sodium sulfate, it was concentrated under reduced pressure to obtain an oily compound A 1
1. t. 09 (yield 70%) was obtained.

以下、物性値を示す。The physical property values are shown below.

I R(neat); W (エステル)/7亭Ocm
−”’ H  NMR ( CDc7!s)  δ;/
.JQ(brs,/AH,CH2)、/.44A(m%
rH,CH2CH2CO),J .3 7 (m,tH
%CH2CO)、J .4Z/ (br s.PH,N
(CHa)s),j.r/ ( s,AH,OCRs)
、i.rr−a.uz(m,rH%CH20  and
  CH2N)j .Oj( s,$8%CH2φ)%
j./j’(m,/H,CHO),4 .III−7 
.j4A (m,tH,φ)?AB−MS ; I 4
 4 ( M+H )実施例2 化合物45 ( n=/J、RggR1−H)の合戚実
施例1に記載の方法に準じて、出発物質を変更して化合
物/l65 i合成した。以下、その物性値を記述する
. I R ( K B r ) ; y ( 工xテル)
i7uocm−””H  NMR(CDα3}δ;/.
Jr(br  s、IJH%CH2 )、t.tz<m
,rH.CH2 CH2 Co冫、  J  .l  
6  (  m,  !rH%CHzCO)、1.lr
(s,  タH,N(CHs)s)、i.to( s.
AH,OCH3)、3.rデー$.$J(m1rH,C
H20  and  CH2N)、!.07(s%4c
H%CH2φ),z ./ I (m,/H,CHO)
、t.rj−7.l4L(rn.IH,  φ》FAB
−M8;f’yr<M+H)” 実施例3 化合物A? ( nm/ u,R=R1−H)の合戚実
施例1に記載の方法■準じて、出発物質を変更して化合
物/l67t−合戚した.以下、、その物性値を記述す
る。
I R (neat); W (ester) / 7-tei Ocm
-”' H NMR (CDc7!s) δ;/
.. JQ(brs,/AH,CH2),/. 44A (m%
rH, CH2CH2CO), J. 3 7 (m,tH
%CH2CO), J. 4Z/ (br s.PH,N
(CHa)s), j. r/ (s, AH, OCRs)
, i. rr-a. uz(m, rH%CH20 and
CH2N)j. Oj(s, $8%CH2φ)%
j. /j' (m, /H, CHO), 4. III-7
.. j4A (m, tH, φ)? AB-MS; I 4
4 (M+H) Example 2 Synthesis of Compound 45 (n=/J, RggR1-H) Compound/l65i was synthesized according to the method described in Example 1 by changing the starting materials. The physical property values are described below. I R (KBr); y (K x Ter)
i7uocm-””H NMR (CDα3}δ;/.
Jr (br s, IJH%CH2), t. tz<m
, rH. CH2 CH2 Co., J. l
6 (m, !rH%CHzCO), 1. lr
(s, taH,N(CHs)s), i. to( s.
AH, OCH3), 3. r day $. $J(m1rH,C
H20 and CH2N),! .. 07(s%4c
H%CH2φ),z. / I (m, /H, CHO)
, t. rj-7. l4L(rn.IH, φ》FAB
-M8; f'yr<M+H)" Example 3 Compound A? (nm/u, R=R1-H) Compound/l67t according to the method described in Example 1, changing the starting material -The properties were described below.

IR(KBr ); y (エステル)/ 7 4A 
O cm−’’ H  NMR ( CDcJ3 )δ
;/.Jr(br  s,uoH,CH2 )、/ −
 4 3 ( ms  r H,CH2CH2CO)、
コ.3r (m,IH,CH2CO)、3.jA(s%
 51’H%N(CHs)s )、J .to( S,
6H,OCH3)  7 .90−II .4(t(m
,rH,CH20  and  CH2N)、1.01
<s,!H,C}12φ》、r ./ t (m% /
H,CHO)、6 .12−7 .744 (m%rH
,  φ》FAB−MS ; t o s←( M+H
 ) +実施例4 化合物41 1 ( n=/f,R=H,Rl =OC
H3)  の合戚 実施例lの記載の方法に準じて、出発物質を変更して化
合物/Mllを合収した。
IR (KBr); y (ester)/7 4A
O cm-''H NMR (CDcJ3)δ
;/. Jr(br s, uoH, CH2), / −
4 3 (ms r H, CH2CH2CO),
Ko. 3r (m, IH, CH2CO), 3. jA(s%
51'H%N(CHs)s), J. to(S,
6H, OCH3) 7. 90-II. 4(t(m
, rH, CH20 and CH2N), 1.01
<s,! H, C}12φ》, r. / t (m% /
H, CHO), 6. 12-7. 744 (m%rH
, φ》FAB-MS; tos←(M+H
) +Example 4 Compound 41 1 (n=/f, R=H, Rl=OC
Synthesis of H3) According to the method described in Example 1, the starting materials were changed and the compound/Mll was synthesized.

物性値 IR(KBr):y(エステル)/74cOcm−’’
H  NMR(CDα3)δ’,i.sr(br  s
4AIH,CH2)/ .t7 (m%fH%CH2C
H2CO)、J .Jj(m,rH.CH2CO)  
J .#Q(s、?H%N(CHa)a)、i.rコ(
S%/2H,OCH3)!.タλ−44.u7(m%t
H,CH20  and  CH2N)、t./O(s
,$HFAB−MS ; t t J t (M+H 
)”実施例5 化合物/I68 ( n=/ #,R=OCHa、Rs
−==zH》の合戚 実施例lの記載の方法に準じて、出発物質に変史して化
合物4 8 t−合戚した。
Physical property value IR (KBr): y (ester)/74cOcm-''
H NMR (CDα3)δ', i. sr(br s
4AIH, CH2)/. t7 (m%fH%CH2C
H2CO), J. Jj (m, rH.CH2CO)
J. #Q(s,?H%N(CHa)a), i. r co(
S%/2H, OCH3)! .. Ta λ-44. u7(m%t
H, CH20 and CH2N), t. /O(s
, $HFAB-MS; t t J t (M+H
)"Example 5 Compound/I68 (n=/#, R=OCHa, Rs
According to the method described in Example 1, the starting material was modified and Compound 4 8 t-merized.

出発原料 NaBH4処理で容易に生戚する既知化合物である。starting material This is a known compound that is easily generated by NaBH4 treatment.

物性値 IR(KBr ); ν<エステル)/ 7uOcm−
’’H  NMR(CDα3)δ;t.3r(br  
s,uOH  CH2)/ ,44A(m,rH、CH
2c}{2co)、J . l F ( m%I H,
CH2CO)J.JP(S、PH%N(CH3)a )
、3.r/<s,/JH%OCHs)  s.yt−a
.to(m,rH,CH20  and  CH2N)
  j./
Physical property value IR (KBr); ν<ester)/7uOcm-
''H NMR (CDα3)δ; t. 3r(br
s, uOH CH2)/ ,44A(m, rH, CH
2c}{2co), J. l F (m% I H,
CH2CO)J. JP(S,PH%N(CH3)a)
, 3. r/<s,/JH%OCHs) s. yt-a
.. to(m, rH, CH20 and CH2N)
j. /

【図面の簡単な説明】[Brief explanation of drawings]

第l図〜第3図はいずれも本発明の化合物の1HNMR
スペクトルを示すチャートであり、第l図は化合物/1
61の、第2図は化合物鷹5の、第3図は化合物/#6
7の1HNMRスペクトルである。
Figures 1 to 3 are 1H NMR of the compounds of the present invention.
This is a chart showing the spectrum, and Figure 1 is a chart showing the spectrum of compound/1.
61, Figure 2 is Compound Hawk 5, Figure 3 is Compound/#6
7 is a 1H NMR spectrum.

Claims (1)

【特許請求の範囲】  下式1で表わされるホスファチジルコリン誘導体。 式1 ▲数式、化学式、表等があります▼ 式中nは8〜22の整数を表わす。 式中RとR_1はアルコキシ基又は水素原子を表わす。[Claims] A phosphatidylcholine derivative represented by the following formula 1. Formula 1 ▲Contains mathematical formulas, chemical formulas, tables, etc.▼ In the formula, n represents an integer of 8 to 22. In the formula, R and R_1 represent an alkoxy group or a hydrogen atom.
JP24096289A 1989-09-18 1989-09-18 Phosphatidylcholine derivative Pending JPH03106891A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24096289A JPH03106891A (en) 1989-09-18 1989-09-18 Phosphatidylcholine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24096289A JPH03106891A (en) 1989-09-18 1989-09-18 Phosphatidylcholine derivative

Publications (1)

Publication Number Publication Date
JPH03106891A true JPH03106891A (en) 1991-05-07

Family

ID=17067246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24096289A Pending JPH03106891A (en) 1989-09-18 1989-09-18 Phosphatidylcholine derivative

Country Status (1)

Country Link
JP (1) JPH03106891A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008088064A (en) * 2006-09-29 2008-04-17 Fujifilm Corp Glyceride compound having bis(trifluoromethyl)phenyl group
JP2009514660A (en) * 2005-10-28 2009-04-09 ソーラーブレ, インコーポレイテッド Photo-responsive microencapsulated materials, compositions and methods for their use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009514660A (en) * 2005-10-28 2009-04-09 ソーラーブレ, インコーポレイテッド Photo-responsive microencapsulated materials, compositions and methods for their use
JP2008088064A (en) * 2006-09-29 2008-04-17 Fujifilm Corp Glyceride compound having bis(trifluoromethyl)phenyl group

Similar Documents

Publication Publication Date Title
RU2001118842A (en) Palladium-substituted derivatives of bacteriochlorophyll and their use
CN113603653B (en) Synthesis method of selenooxazolidine-2, 4-dione promoted by visible light
JPH03106891A (en) Phosphatidylcholine derivative
Rousselle et al. Development of a novel highly anti-proliferative family of gold complexes: Au (i)-phosphonium-phosphines
ES2449494T3 (en) Procedure for the production of 9-cis-retinoic acid
EP1084712B1 (en) X-ray contrast agents
EP2758391A1 (en) Luminescent probes for biological marking and imagery, and preparation method thereof
JP4210744B2 (en) Sphingolipid derivatives
JP2756603B2 (en) Photoresponsive liposomes
CN109761927A (en) A kind of high enantioselectivity tricyclic structure containing cyclohexenone analog compound, preparation method and application
JP3619265B2 (en) Ascorbic acid-inositol conjugate or salt thereof, and method for producing the same
JP3477631B2 (en) Purification method of 1,3-bis (3-aminopropyl) -1,1,3,3-tetraorganodisiloxane
JPH08188592A (en) Ascorbic acid-arbutin combination or its salt and its production
SU677357A1 (en) Derivatives of 5,6-dihydrodipyrimido(4,5-b)(5,4-f)-(1,4)thiazepine and method of producing same
KR20000061780A (en) Process for preparing iopromide
JPH07504434A (en) Synthesis of stable, water-soluble chemiluminescent 1,2-dioxetanes and their intermediates
JPH0834769A (en) Vitamin d derivative containing substituent group at second position
SU1731776A1 (en) Method of producing 1-(1-bromo-2-hydroxyethyl)silatranes
JP3055234B2 (en) Spiropyridopyrane compound and guanine indicator using the same
FR2973030A1 (en) COMPOUNDS WITH CHROMOPHORE AND PHOTOREACTIVE GROUPS
SU1351934A1 (en) Method of obtaining polyfunctional sulfur-containing spirocyclic iminodihydrofurans
JPS6136513B2 (en)
JPS62230759A (en) Novel acryl or methacrylamide derivative
JPH11171812A (en) Benzyl ether-based dendrimer compound
JP2014065706A (en) Cage-shaped silsesquioxane derivative